Travoprost

曲伏前列素

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameTravoprost
Drug Alias NameTravoprost-APS曲伐前列素Travoprostum曲沃前列素曲伏前列腺素 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor agonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucoma, Angle-ClosureGlaucoma +[4] 
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2001/03/16
Country/TerritoryUnited StatesMexicoAustralia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesAlconGlaukos CorpNovartis Europharm Ltd +[4] 
Inactive CompaniesLaboratorios Sophia Sa De CvAlcon Pharmaceuticals LtdEnvisia Therapeutics Inc +[4] 
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsGlaucoma, Angle-Closure

Other Information

ATC CodeS01EE04
Related LinksWikipediaDrugBankKEGG